PBF-1129
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PBF-1129, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer [Phase 1]